CANMAB (TRASTUZUMAB) 440 MG

Canmab 440 Injection is used for the treatment of a certain type of cancer of the breast and the stomach that has spread to different parts of the body. It is also used to prevent the relapse of certain cancers. It is either used alone or in a combination with other anti-cancer medications.

CANMAB (Trastuzumab) Injection suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship CANMAB (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. CANMAB is manufactured by Biocon Limited.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for CANMAB (Trastuzumab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

CANMAB is a biosimilar version of Roche’s HER2-positive breast cancer treatment Herceptin (trastuzumab).

CANMAb™ is a targeted therapy for the treatment of HER2 – positive breast cancer and acts by interfering with HER2 protein production and stopping the growth of cancer cells. It is easy to administer and will be given intravenously, once every 3 weeks or on a weekly basis depending on the patient’s condition. Unlike the product currently available in the market, both 150 and 440 mg formulations of CANMAb™ can be stored for 1 month which is an important offering for patients in India, as it will ensure that there is no underdosing or wastage of drug which is quite common today.

Medicine Name: CANMAB Injection
Generic Name: Trastuzumab
Approval Date: Jan 18, 2014
Available as (Form & Strength): 440 mg Injection
Company Name: Biocon Limited

Please contact +91 9818274099 for CANMAB price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer�s requirements.